PartnerRe Asset Management’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,752
Closed -$244K 129
2016
Q1
$244K Hold
1,752
0.12% 127
2015
Q4
$244K Sell
1,752
-2,982
-63% -$411K 0.13% 130
2015
Q3
$663K Sell
4,734
-44
-0.9% -$6.61K 0.11% 131
2015
Q2
$784K Sell
4,778
-874
-15% -$140K 0.15% 125
2015
Q1
$873K Sell
5,652
-97
-2% -$13.8K 0.15% 123
2014
Q4
$722K Buy
5,749
+729
+15% +$90.1K 0.12% 146
2014
Q3
$600K Sell
5,020
-927
-16% -$106K 0.12% 148
2014
Q2
$640K Sell
5,947
-879
-13% -$90.6K 0.11% 165
2014
Q1
$680K Sell
6,826
-285
-4% -$25.8K 0.11% 171
2013
Q4
$657K Sell
7,111
-509
-7% -$45.2K 0.11% 163
2013
Q3
$637K Sell
7,620
-1,047
-12% -$89.7K 0.11% 157
2013
Q2
$709K Buy
+8,667
New +$649K 0.11% 150

Other funds holding ELV

PartnerRe Asset Management's ELV Position: Q2 2016 in Review

PartnerRe Asset Management sold out of Elevance Health (ELV) in Q2 2016, closing a stake of 1,752 shares — an estimated $244K sold.

PartnerRe Asset Management first reported a position in ELV in Q2 2013 and held it in 12 quarters. The position peaked at $873K in Q1 2015. 761 funds tracked by Wall St. Rank hold ELV as of Q2 2016.

  • PartnerRe Asset Management reported no remaining Elevance Health position as of Q2 2016 after selling out during the quarter.
  • PartnerRe Asset Management sold 1,752 Elevance Health shares in Q2 2016, an estimated $244K.
  • PartnerRe Asset Management first reported a position in Elevance Health in Q2 2013 and held it in 12 quarters.
  • PartnerRe Asset Management's Elevance Health position peaked at $873K in Q1 2015.
  • 761 funds tracked by Wall St. Rank held Elevance Health as of Q2 2016.

Based on PartnerRe Asset Management's 13F filing for Q2 2016, filed 14 Jul 2016.